Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-28

Clinical Trial Update: Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial update showing enrollment by invitation for Cytosponge as surveillance after endoscopic submucosal dissection in esophageal squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changhai Hospital | Conditions: Esophageal Squamous Cell Carcinoma | NA | Status: ENROLLING_BY_INVITATION